Shares of Syncona (LON:SYNC – Get Free Report) reached a new 52-week high on Monday . The stock traded as high as GBX 118.69 and last traded at GBX 118.69, with a volume of 1086872 shares. The stock had previously closed at GBX 111.60.
Analyst Ratings Changes
Separately, Peel Hunt reissued a “buy” rating and set a GBX 189 target price on shares of Syncona in a research note on Tuesday, August 4th. One equities research analyst has rated the stock with a Buy rating, According to MarketBeat.com, the stock presently has an average rating of “Buy” and a consensus price target of GBX 189.
Get Our Latest Stock Analysis on Syncona
Syncona Stock Up 1.9%
About Syncona
Syncona’s purpose is to invest to extend and enhance human life. We do this by creating, building and scaling companies to deliver transformational treatments to patients in areas of high unmet need. We aim to build and maintain a diversified portfolio of 20-25 globally leading life science businesses, across development stage, modality and therapeutic area, for the benefit of all our stakeholders. We focus on developing treatments that deliver patient impact by working in close partnership with world-class academic founders and experienced management teams.
Read More
- Five stocks we like better than Syncona
- Meta’s Muse Highlights Arm’s Growing Role in AI Infrastructure
- Oura’s $15.6 Billion IPO Is Betting Investors See More Than a Smart Ring
- AMD Chips Away at NVIDIA’s AI Throne
- Is the Fed Playing Chess With Rates—Or Just Behind the Curve Again?
Receive News & Ratings for Syncona Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Syncona and related companies with MarketBeat.com's FREE daily email newsletter.
